Pediatric Experiences in Myelodysplastic Syndrome

Decision letter for "The Incidence, Risk Factors and Survival of Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome: A Population‐Based Study"

10.1002/hon.2660/v3/decision1 ◽

2019 ◽

Keyword(s):

Risk Factors ◽

Acute Myeloid Leukemia ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Population Based ◽

Population Based Study ◽

Incidence Risk ◽

Acute Myeloid

Download Full-text

Author response for "The Incidence, Risk Factors and Survival of Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome: A Population‐Based Study"

10.1002/hon.2660/v2/response1 ◽

2019 ◽

Author(s):

Xingnong Ye ◽

Dan Chen ◽

Yan Zheng ◽

Cai Wu ◽

Xiaoqiong Zhu ◽

...

Keyword(s):

Risk Factors ◽

Acute Myeloid Leukemia ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Population Based ◽

Author Response ◽

Population Based Study ◽

Incidence Risk ◽

Acute Myeloid

Download Full-text

Decision letter for "The Incidence, Risk Factors and Survival of Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome: A Population‐Based Study"

10.1002/hon.2660/v2/decision1 ◽

2019 ◽

Keyword(s):

Risk Factors ◽

Acute Myeloid Leukemia ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Population Based ◽

Population Based Study ◽

Incidence Risk ◽

Acute Myeloid

Download Full-text

Alkylating Agent-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome

10.32388/p7v2fx ◽

2020 ◽

Author(s):

Keyword(s):

Acute Myeloid Leukemia ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Alkylating Agent ◽

Acute Myeloid

Download Full-text

Point Mutations in the AML1/RUNX1 Gene Associated with Myelodysplastic Syndrome

Critical Reviews in Eukaryotic Gene Expression ◽

10.1615/critreveukargeneexpr.v15.i3.10 ◽

2005 ◽

Vol 15 (3) ◽

pp. 183-196 ◽

Cited By ~ 7

Author(s):

Hironori Harada ◽

Yuka Harada

Keyword(s):

Myelodysplastic Syndrome ◽

Point Mutations ◽

Runx1 Gene

Download Full-text

A Case of Pyoderma Gangrenosum Associated with Myelodysplastic Syndrome

Nishi Nihon Hifuka ◽

10.2336/nishinihonhifu.74.589 ◽

2012 ◽

Vol 74 (6) ◽

pp. 589-594 ◽

Cited By ~ 1

Author(s):

Etsuko YAMASHIRO ◽

Osao ARAKAKI ◽

Hitoshi ARAKAKI ◽

Takuya MIYAGI ◽

Sayaka YAMAGUCHI ◽

...

Keyword(s):

Myelodysplastic Syndrome ◽

Pyoderma Gangrenosum

Download Full-text

HDM201 in Combination With MBG453 or Venetoclax in Patients With Acute Myeloid Leukemia (AML) or High-risk Myelodysplastic Syndrome (MDS)

Case Medical Research ◽

10.31525/ct1-nct03940352 ◽

2019 ◽

Author(s):

Keyword(s):

Acute Myeloid Leukemia ◽

High Risk ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Acute Myeloid

Download Full-text

Pembrolizumab and Decitabine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome That Is Newly-Diagnosed, Recurrent, or Refractory

Case Medical Research ◽

10.31525/ct1-nct03969446 ◽

2019 ◽

Author(s):

Keyword(s):

Acute Myeloid Leukemia ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Newly Diagnosed ◽

Acute Myeloid

Download Full-text

An Open Label Dose Escalation Trial of CA-4948 in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Case Medical Research ◽

10.31525/ct1-nct04278768 ◽

2020 ◽

Author(s):

Keyword(s):

Myelodysplastic Syndrome ◽

Dose Escalation ◽

Acute Myelogenous Leukemia ◽

Myelogenous Leukemia ◽

Open Label ◽

Label Dose ◽

Acute Myelogenous

Download Full-text

Faculty Opinions recommendation of Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.10197.467594 ◽

2006 ◽

Author(s):

Mayumi Mori

Keyword(s):

Acute Myeloid Leukemia ◽

High Risk ◽

Myelodysplastic Syndrome ◽

Myeloid Leukemia ◽

Prognostic Models ◽

Intensive Chemotherapy ◽

Acute Myeloid

Download Full-text